Prostate cancer decisions — 2021

The Board has remanded the claims for service connection due to insufficient medical opinions regarding the relationship between the Veteran's disabilities and his military service. The appellant is seeking service connection for bilateral kidney disability, prostate cancer, and left ankle disability.

The Board has denied a compensable initial rating for erectile dysfunction and remanded the issue of a compensable initial rating for residuals of prostate cancer due to insufficient evidence in the record.

The Veteran's prostate cancer is rated at 100 percent permanent and total, granted a permanent and total disability rating.

The Board has remanded the claims for service connection for arthritis, COPD, heart disease, and prostate cancer to seek verification of in-service exposure to an herbicide agent. The Veteran's alleged exposure occurred during his active duty in Germany from April 1968 to April 1970.

The Veteran's prostate cancer residuals are rated at 40 percent from February 1, 2011 to November 11, 2020 and at 60 percent from November 12, 2020 forward. The Board has remanded the issues of initial rating for bowel impairment and TDIU due to service-connected disabilities.

The Board denied service connection for a left shoulder disability, prostate cancer, and obstructive sleep apnea (OSA) due to the lack of evidence linking these conditions to active duty service.,There is no direct evidence showing that the Veteran's current disabilities are related to his military service.

The Veteran's appeal for service connection of various conditions, including a prostate disorder, has been remanded due to insufficient evidence. The left little finger disorder claim was granted to reopen but remains pending on the merits.

The Board denied the Veteran's claims of service connection for prostate cancer, renal disability, erectile dysfunction, bilateral peripheral neuropathy of the upper and lower extremities, as well as his request for an increased rating for TIA. The Board found that there was no evidence linking these conditions to his service or secondary to his service-connected diabetes mellitus.

The Board denied service connection for heart disability, prostate cancer, and COPD. The right knee degenerative arthritis claim was granted with a separate rating for left knee strain.

The Veteran's prostate cancer residuals are rated at 60 percent effective January 1, 2015. The rating is based on urinary frequency issues.

The Veteran's heart condition, diabetes mellitus type II, prostate cancer, kidney condition (secondary to diabetes), right upper and lower extremity diabetic peripheral neuropathy, and tinnitus have all been granted service connection based on evidence of herbicide exposure during active duty.,Service connection for bilateral hearing loss and skin condition are remanded.

The Board has remanded the Veteran's claims for service connection for prostate cancer, skin cancer, and Alzheimer's dementia due to alleged exposure to herbicide agents (Agent Orange) and/or ionizing radiation during his active duty in Okinawa. The AOJ is required to verify this exposure and obtain a dose estimate if necessary.

The Veteran's claim for service connection for residuals of dengue fever is granted. However, the claim for service connection for prostate cancer to include as secondary to toxic herbicide exposure (Agent Orange) is denied.

The Veteran's claims for service connection for ischemic heart disease and prostate cancer have been granted due to presumed exposure to herbicide agents while serving in the waters within 12 nautical miles offshore of Vietnam during the Vietnam War era.

The Veteran's prostate cancer is presumed related to his in-service herbicide agents exposure during his active military service in Korea.

The Board has determined that the Veteran's claimed disabilities, including back disability, right and left hip disabilities, cold injury residuals of the feet, prostate cancer, peripheral vascular disease, and osteoporosis, were not incurred or aggravated during active service. The evidence does not support a finding of direct service connection.

The Board denied service connection for prostate cancer, finding that it was not incurred in or related to service and could not be presumed due to exposure at Camp Lejeune. The medical evidence did not support a direct link between the condition and service.

The Veteran's claim for increased ratings of his coronary artery disease (CAD) and residuals of prostate cancer were denied. The ED claim was also denied.,For CAD, the Veteran did not meet the criteria for a higher rating prior to March 26, 2019, or from that date onwards. For prostate cancer, the Veteran's condition did not warrant an increased rating prior to June 2, 2020, but was rated at 20% thereafter.

The Veteran's claim for service connection for prostate cancer has been denied.,The Veteran's claim for service connection for hepatitis C is remanded and will be reviewed again.

The Veteran's appeal regarding the restoration of a 100% rating for his service-connected prostate cancer, and whether the reduction to a 60% rating was proper, has been dismissed due to the Veteran's death.